2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors
A technology of derivatives and amino groups, applied in the field of compounds of Wee-1 kinase activity inhibitors
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0250] Example 1: 6-(2,6-dichlorophenyl)-2-((4-(piperazin-1-yl)phenyl)amino)pyrido[4,3-d]pyrimidine -5(6H)-one
[0251]
[0252] Step 1: N-(2,6-dichlorophenyl)-4-methyl-2-(methylthio)pyrimidine-5-carboxamide: Phosphorus trichloride (2.37 mL , 27.1 mmol) was added to 4-methyl-2-(methylthio)pyrimidine-5-carboxylic acid (5.00 g, 27.1 mmol) [commercially available] and 2,6-dichloroaniline (4.40 g, 27.1 mmol) In a stirred solution in chlorobenzene (100 mL). After 3 h, the solvent was removed under vacuum and the remaining residue was partitioned between DCM and 2M sodium carbonate (aq) solution, separated, extracted (DCM x 2) and dried (phase separator) and removed under vacuum solvent to give the title compound (6.86 g, 77%) as a light yellow solid. LCMS (Method A): R T = 1.14 minutes, m / z = 328, 330 [M+H] + .
[0253] Step 2: 6-(2,6-Dichlorophenyl)-2-(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one: at room temperature under nitrogen, DMF -DMA (2.49mL, 18.6mmol) was adde...
Embodiment 2
[0257] Example 2: 6-(2,6-dichlorophenyl)-8-methyl-2-((4-(piperazin-1-yl)phenyl)amino)pyrido[4,3-d] pyrimidine pyridin-5(6H)-one
[0258]
[0259] Step 1: 8-bromo-6-(2,6-dichlorophenyl)-2-(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one: at 80°C under nitrogen 6-(2,6-Dichlorophenyl)-2-(methylthio)pyrido[4,3-d]pyrimidine-5 In a stirred solution of (6H)-ketone (10.0 mg, 0.030 mmol) in acetonitrile (1.0 mL). After 16 hours, LCMS analysis showed a 2:1 product / SM mixture. Additional NBS (2.6 mg, 0.5 equiv) was added. After another 1 h, the reaction mixture was quenched with 10% sodium bisulfite and partitioned with DCM, separated, extracted (DCM x 2), dried (phase separator), solvent removed in vacuo and flash chromatography (in ring Purification of the remaining residue (EtOAc in hexanes 0% to 100%) gave the title compound (9.5 mg, 77%) as a pale yellow solid. LCMS (Method A): R T = 1.47 minutes, m / z = 418 [M+H] + .
[0260] 1 HNMR (500MHz, CDCl 3 ): δ9.36(s, 1H), 7.56(s...
Embodiment 3
[0265] Example 3: 6-(2-chloropyridin-3-yl)-2-((4-(piperazin-1-yl)phenyl)amino)pyrido[4,3-d]pyrimidine -5(6H)-one
[0266]
[0267] Step 1: N-(2-Chloropyridin-3-yl)-4-methyl-2-(methylthio)pyrimidine-5-carboxamide: Phosphorus trichloride (0.047 mL , 0.543mmol) was added to 4-methyl-2-(methylthio)pyrimidine-5-carboxylic acid (100mg, 0.543mmol) and 2-chloropyridin-3-amine (69.8mg, 0.543mmol) in chlorobenzene ( 2.0 mL) in a stirred solution. After 16 hours, the solvent was removed in vacuo and the remaining residue was purified by flash chromatography (0% to 100% EtOAc in cyclohexane) to give the title compound (53.3 mg, 33%) as a pale yellow solid. LCMS (Method A): R T = 0.98 minutes, m / z = 295 [M+H] + .
[0268] Step 2: 6-(2-Chloropyridin-3-yl)-2-(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one: DMF at room temperature under nitrogen -DMA (0.048mL, 0.362mmol) was added to N-(2-chloropyridin-3-yl)-4-methyl-2-(methylthio)pyrimidine-5-carboxamide (53.3mg, 0.181mmol) in A st...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com